Clinical trial

A Dose Ranging Study of Different Strengths of Spinosad Topical Creme in…

NCT00311779 · ParaPRO LLC, Industry · Completed

Key facts

NCT number NCT00311779
Title A Dose Ranging Study of Different Strengths of Spinosad Topical Creme in Subjects With Pediculosis Capitis
Official title Phase 2 Study of Efficacy and Safety of Different Strengths of Spinosad Topical Creme Rinse (0%, 0.5% or 1.0%) in Subjects 2 Years of Age or Older With Pediculosis Capitis - A Dose Ranging Study
Lead sponsor ParaPRO LLC, Industry
Status Completed
Phase Phase 2
Study type Interventional
Conditions Pediculosis Capitis (Head Lice)
Intervention type Drug
Interventions Spinosad Creme Rinse
Enrollment 120
Start date Mar 1, 2006
Completion Jul 1, 2006
First posted Apr 6, 2006
Last update posted Jul 12, 2006
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies